Lepu Rapid rapid test MSLRDT120 for sale

A rapid test for the qualitative detection of the neutralizing

antibodies to the SARS-CoV-2 or its vaccines in whole blood, serum, or plasma. 

Package Specification: 40 T/kit, 20 T/kit, 10 T/kit, 1 T/kit. 

Relative Sensitivity: 96.97%（95%CI：83.35%～99.99%）
Relative Specificity: 100.00%（95%CI：97.29%～100.00%） 
Accuracy: 99.50%（95%CI：96.94%～99.99%）

Foil pouches,with test casssttes and desiccants *20
Assay buffer *20 vials; 
Disposable droppers*20;
Lancet *20
Lodine swab*20
Instruction for use*1

Lepu Rapid rapid test MSLRDT120  INTENDED USE 
The SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) is a rapid chromatographic immunoassay for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in whole blood, serum, or plasma. 

Lepu Rapid rapid test MSLRDT120   PRINCIPLE 
The SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) is for detection antibodies to SARS-CoV-2 or its vaccines. The cell surface receptor angiotensin converting enzyme-2 (ACE2) are coated in the test line region and the recombinant receptor-binding domain (RBD) conjugated with the indicate particles. 

During testing, if there are SARS-CoV-2 neutralizing antibodies in the specimen, it would react with the protein RBD-particle conjugate and not react with the pre-coated protein ACE2. The mixture then migrates upward on the membrane chromatographically by capillary action and would not captured by the pre-coated antigen. The SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) contains protein RBD-coated particles. The protein ACE2 are coated in the test line region.